Allakos Inc (NQ: ALLK )
0.8406
-0.0392
(-4.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
All News about Allakos Inc
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Where Allakos Stands With Analysts
December 18, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
What 4 Analyst Ratings Have To Say About Allakos
November 28, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600.png)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From Allakos Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2024/01/17/netflix_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/16/image_5.jpg?width=1200&height=800&fit=crop)
Gold Down 1%; PNC Financial Posts Upbeat Earnings
January 16, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/16/crude_oil_-_logo.jpg?width=1200&height=800&fit=crop)
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
January 16, 2024
Via Benzinga
Topics
Stocks
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1392564872.png)
![](https://cdn.benzinga.com/files/images/story/2024/biotech-shutter.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/16/image41.jpg?width=1200&height=800&fit=crop)
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
January 16, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From Allakos Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/18/allakos.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/58aeb59e-2de0-4f25-a39b-cd7e644f9fc1/small/allakos-jpg.jpg)
From Allakos Inc.
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/27/allk_0.png?width=1200&height=800&fit=crop)
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
September 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.